Calendar Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
24.46 USD -0.12% Intraday chart for Mirum Pharmaceuticals, Inc. +2.73% -17.14%

Chart calendar Mirum Pharmaceuticals, Inc.

393f5f4f0340e41049b4773.NlCHw1-9x3RagykNSTOboalU1gbDN-BIwhYW-3QMgfQ.bGXXkyfRgS4z4l9pOkbQysJsvDWub4QxmHxJkDB68aYOPuKZb_KoB2nraA~cf85a86eff2aa928350e339bbf2199ff

Upcoming events on Mirum Pharmaceuticals, Inc.

01/05/2024 Q1 2024 Earnings Release (Projected)
31/07/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
04/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Mirum Pharmaceuticals, Inc.

12/03/2024 Barclays Global Healthcare Conference
12/03/2024 19:00 Leerink Partners Global Biopharma Conference
28/02/2024 21:30 Q4 2023 Earnings Call
28/02/2024 21:03 Q4 2023 Earnings Release
10/01/2024 18:30 JPMorgan Healthcare Conference
28/11/2023 20:25 Evercore ISI HealthCONx Conference
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference - Poster Number - 4547-C
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference - Poster Number - 4605-C
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference - Poster Number - 4604-C
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference - Poster Number - 4602-C
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference - Poster Number - 5048-C
08/11/2023 19:00 UBS BioPharma Conference - Fireside Chat
02/11/2023 20:30 Q3 2023 Earnings Call
02/11/2023 20:05 Q3 2023 Earnings Release
07/10/2023 20:00 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No
07/10/2023 20:00 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No
07/10/2023 20:00 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No
07/10/2023 20:00 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No
07/10/2023 18:30 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract 53
06/10/2023 20:00 North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
8,33
-
19,1
78,4
-75.6%
77,1
74,1
3.93%
186
185
0.96%

316

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-173
-169
-2.26%
-128
-138
7.01%
0,00
-101
-

-45,8

EBIT
Million USD
Released
Forecast
Spread
-54,7
-53,1
-3%
-104
-91,8
-13.67%
-173
-141
-22.67%
-131
-132
0.81%
-107
-95,3
-11.91%

-69,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-52,5
-51,7
-1.61%
-103
-90,1
-14.64%
-84,0
-137
38.87%
-142
-145
1.86%
-160
-139
-15.44%

-77,1

Net income
Million USD
Released
Forecast
Spread
-52,6
-51,7
-1.65%
-103
-90,1
-14.65%
-84,0
-129
34.7%
-136
-137
1.18%
-161
-141
-14.39%

-58,9

EPS
USD
Released
Forecast
Spread
-4,58
-3,68
-24.46%
-4,09
-3,57
-14.49%
-2,77
-4,51
38.62%
-4,02
-3,92
-2.61%
-3,94
-3,45
-14.18%

-1,13

Announcement Date12/03/2009/03/2109/03/2208/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
3,14
62,7
-94.99%
12,9
8,46
52.33%
17,5
15,4
13.41%
18,8
20,8
-9.75%
27,9
25,1
11.27%
31,6
30,8
2.62%
37,5
30,4
23.17%
47,7
38,6
23.66%
69,6
67,9
2.5%

70,2


75,4


82,5


89,2


94,2

EBITDA
Million USD
Released
Forecast
Spread
-45,2
-41,0
-10.32%
-32,4
-36,0
10.02%
-30,8
-27,0
-14.23%
-31,4
-32,0
1.74%



-25,8
-27,0
4.4%







-10,0


-20,4


-18,5


-11,9


-6,12




EBIT
Million USD
Released
Forecast
Spread
-45,6
-13,1
-247.01%
-32,7
-43,6
24.95%
-31,4
-35,8
12.08%
-32,9
-31,8
-3.51%
-34,2
-32,0
-6.8%
-27,1
-30,7
11.56%
-24,3
-27,6
11.99%
-25,1
-27,9
9.85%
-30,1
-11,3
-165.45%

-25,5


-23,4


-17,3


-12,8


-3,07

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
57,6
4,37
1217.96%
-36,6
-45,8
20.14%
-33,5
-37,7
11.27%
-35,7
-34,1
-4.66%
-36,3
-38,6
5.91%
-29,9
-33,9
11.65%
-73,7
-29,7
-147.92%
-23,3
-28,4
17.7%
-32,9
-11,2
-194.88%

-26,3


-25,5


-17,4


-14,0




Net income
Million USD
Released
Forecast
Spread
57,5
13,1
339.08%
-36,6
-43,6
16.11%
-26,9
-36,8
26.82%
-35,7
-34,9
-2.25%
-36,4
-36,5
0.07%
-30,1
-33,7
10.59%
-74,0
-29,5
-150.74%
-23,6
-28,2
16.43%
-33,1
-12,6
-164.01%

-21,6


-20,1


-13,1


-9,70




EPS
USD
Released
Forecast
Spread
1,91
0,30
529.49%
-1,17
-1,40
16.5%
-0,84
-1,15
27.2%
-1,02
-1,07
4.65%
-0,99
-1,02
2.55%
-0,80
-0,94
14.81%
-1,94
-0,80
-143.89%
-0,57
-0,63
9.27%
-0,63
-0,25
-151.9%

-0,40


-0,36


-0,27


-0,18


-0,12

Announcement Date09/03/2205/05/2204/08/2209/11/2208/03/2304/05/2303/08/2302/11/2328/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MIRM Stock
  4. Calendar Mirum Pharmaceuticals, Inc.